Search clinical trials for: Angiotensin II type 1 receptor antagonists

Total 3854 results

National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function

Myocardial Infarction | Hypertension | Atherosclerosis | Heart Failure, Congestive

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function

Myocardial Infarction | Hypertension | Atherosclerosis | Heart Failure, Congestive

United States
Massachusetts General Hospital

Completed

Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

United States
Children's Hospital Medical Center, Cincinnati

Completed

Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD

Eosinophilic Esophagitis | Connective Tissue Disorders

United States
Henning Bundgaard

Completed

Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy (INHERIT)

Hypertrophic Cardiomyopathy

Denmark
Children's Hospital Medical Center, Cincinnati

Recruiting

Losartan for Diffuse Myocardial Fibrosis in Sickle Cell Disease

Sickle Cell Disease | Diffuse Myocardial Fibrosis

United States
Ain Shams University

Recruiting

Effect of Losartan on the Incidence and Severity of Chemotherapy-Induced Mucositis in Gastrointestinal Cancer Patients

Colorectal Cancer | Chemotherapy | Oral Mucositis | Intestinal Mucositis

Egypt
Norwegian University of Science and Technology
AstraZeneca

Completed

Prophylactic Treatment of Episodic Cluster Headache

Cluster Headache

Norway
Cristina Avendaño Solá

Recruiting

Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial) (EARLY-GENE)

Cardiomyopathy, Dilated

Spain
Abraham Edgar Gracia-Ramos
National Polytechnic Institute, Mexico

Completed

Telmisartan in Respiratory Failure Due to COVID-19 (STAR-COVID)

COVID-19 | Respiratory Insufficiency | Respiratory Distress Syndrome, Adult | Telmisartan

Mexico
Cairo University

Completed

Telmisartan Versus Enalapril in Heart Failure With Reduced Ejection Fraction Patients With Moderately Impaired Kidney Functions (TRIUMF)

Renal Insufficiency | Heart Failure With Reduced Ejection Fraction

Egypt
Novartis Pharmaceuticals

Completed

Double-dose Valsartan Monotherapy in Hypertension Treatment: an Effectiveness and Safety Evaluation in Chinese Patients.

Hypertension

China
Stanford University
Novartis Pharmaceuticals

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Cerebrovascular Accident

United States
University of Erlangen-Nürnberg Medical School

Completed

Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome

Metabolic Syndrome

Germany
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Chinese Hypertensive Diabetics With Microalbuminuria

Hypertension

China
Providence Health & Services
AstraZeneca

Completed

Angiotensin II Antagonism of TGF-Beta 1

Hypertension | Diabetic Nephropathy

United States
Sharp HealthCare

Completed

Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection

SARS-CoV Infection

United States
NYU Langone Health

Not yet recruiting

Losartan Use to Mitigate Arthrofibrosis Following Total Joint Arthroplasty

Arthrofibrosis of Knee

United States
Bassett Healthcare
Goshen Health System; Reid Health

Terminated

COVID MED Trial - Comparison Of Therapeutics for Hospitalized Patients Infected With COVID-19 (COVIDMED)

SARS-CoV-2 Infection

United States
Hospital Clínico Universitario de Valladolid

Completed

CandeSpartan Study. Candesartan Spanish Response-prediction and Tolerability Study (CandeSpartan)

Migraine | Head Pain

Spain
Brigham and Women's Hospital

Suspended

Preeclampsia: A Marker for Future Cardiovascular Risk in Women

Preeclampsia | Pregnancy Induced Hypertension

United States
Stanford University

Withdrawn

Blood Pressure Lowering in Acute Stroke Trial (BLAST)

Stroke, Acute

United States
Atrial Fibrillation Network
Daiichi Sankyo, Inc.

Completed

Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation

Atrial Fibrillation | Arrhythmia | Heart Disease
Sanofi
Bristol-Myers Squibb

Completed

ARCHIPELAGO: Irbesartan in Patients With Acute Coronary Syndrome Without ST Segment Elevation

Myocardial Ischemia | Hypertension

France, Spain, Italy, Belgium, Canada, Germany, Hungary, United States, Netherlands, United Kingdom, Switzerland
RWTH Aachen University
Bayer; Heidelberg University; CTCA

Terminated

Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels (ITEM)

Arterial Hypertension | Diabetes Mellitus Type 2 IRC or NIR

Germany
City Hospitals Sunderland NHS Foundation Trust
Takeda

Unknown

Acute Candesartan Cilexetil Outcomes Stroke Trial (ACCOST)

Cerebrovascular Accident | Acute Stroke

United Kingdom
Connolly, Stuart, M.D.
Bristol-Myers Squibb; Sanofi

Unknown

Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

Hypertension | Atrial Fibrillation

Canada
Norwegian University of Science and Technology
St. Olavs Hospital; Alesund Hospital; Namsos Hospital; Volvat Medisinsk Senter...

Recruiting

Bariatric Surgery and Pharmacokinetics of Candesartan

Obesity, Morbid

Norway
University of Erlangen-Nürnberg Medical School
Bristol-Myers Squibb

Completed

Effect of Irbesartan on Endothelial Function of the Retinal Vasculature in Patients With Hypercholesterolemia

Hypercholesterolemia

Germany
Novartis Pharmaceuticals

Completed

A Study to Evaluate the Long-term Use of Valsartan in Children 6 Months to 5 Years Old With Hypertension

Hypertension

Belgium, Turkey, Hungary, United States, Italy, India, Poland, France, South Africa, Brazil
Novartis

Completed

Effect of Valsartan on Lipid Subfractions in Hypertensive Patients With Metabolic Syndrome

Hypertension | Metabolic Syndrome

Germany, Switzerland
Boehringer Ingelheim

Completed

Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension

Hypertension
Boehringer Ingelheim

Completed

Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients

Hypertension
Ranbaxy Laboratories Limited

Completed

Bioequivalence Study of Valsartan 320mg Tablets Under Fed Conditions

Healthy

India
Kagoshima University

Unknown

Kagoshima Collaborate Trial in Metabolic Syndrome (KACT Study) (KACT)

Hypertension | Obesity

Japan
Sanofi
Bristol-Myers Squibb

Completed

Irbesartan in Hypertension

Hypertension

Turkey
Odense University Hospital

Unknown

Effect of Angiotensin II Receptor Blockers (ARB) on Left Ventricular Reverse Remodelling After Aortic Valve Replacement in Severe Valvular Aortic Stenosis

Atrial Fibrillation | Aortic Valve Stenosis | Left Ventricular Hypertrophy

Denmark
Sanofi
Bristol-Myers Squibb

Completed

APROVE : Irbesartan in Hypertension

Hypertension

Algeria
Sanofi
Bristol-Myers Squibb

Completed

Evaluation of Efficacy and Safety of the Dosage Adjustment of Aprovel® (Irbesartan) in Hypertensive Outpatients in Current Clinical Practice

Hypertension

Tunisia
Medical University of Lodz

Completed

Effect of Losartan or Eprosartan on Fructose Hyperuricemia (metabolic)

Uric Acid Concentration, Serum, Quantitative Trait Locus 7
Takeda

Completed

A Study of TAK-536 in Children From 2 to Less Than 6 Years Old With High Blood Pressure

Hypertension

Japan
Palo Alto Veterans Institute for Research
Medtronic; James Cook University, Queensland, Australia

Completed

Study of the Effectiveness of Telmisartan in Slowing the Progression of Abdominal Aortic Aneurysms (TEDY)

Abdominal Aortic Aneurysm

United States
Roxane Laboratories

Completed

Crossover Bioequivalence Study of Irbesartan 300 mg Tablets Under Fed Conditions

Hypertension

United States
Ain Shams University

Completed

Chronopharmacology of Valsartan in Normotensive Subjects

Healthy Normotensive Volunteers

Egypt
Jiangsu HengRui Medicine Co., Ltd.

Completed

The Drug-drug Interaction of SP2086 and Valsartan

Type 2 Diabetes

China
Bristol-Myers Squibb
Sanofi

Completed

Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)

Congestive Heart Failure

Netherlands, Portugal, Spain, United States, Belgium, Italy, Argentina, Brazil, Canada, France, Germany, Mexico, South Africa, Sweden, Australia, Russian Federation, Poland, Czech Republic, Denmark, Ireland, Hungary, Switzerland, Gr... and more
Karin Skov
AstraZeneca; University of Aarhus

Unknown

Danish Hypertension Prevention Project - DHYPP

Hypertension

Denmark
Fundación Cardiovascular de Colombia
AstraZeneca

Terminated

Clinical Trial to Assess the Effects of Candesartan on the Carbohydrate Metabolism of Obese Subjects (ARAMIA)

Obesity | Glucose Intolerance

Colombia
Seung-Jung Park
Novartis

Completed

Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent (VAL-SUPPRES)

Coronary Artery Disease

Korea, Republic of
Osaka City University

Completed

Prevention of CHOP-induced Chronic Cardiotoxicity

Non-Hodgkin's Lymphoma

Japan

Search clinical trials for: Angiotensin II type 1 receptor antagonists

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Serbia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations